Cargando…
Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027844/ https://www.ncbi.nlm.nih.gov/pubmed/35456206 http://dx.doi.org/10.3390/jcm11082115 |
_version_ | 1784691468530614272 |
---|---|
author | Lobenwein, Daniela Huber, Rosalie Kerbler, Lars Gratl, Alexandra Wipper, Sabine Gollmann-Tepeköylü, Can Holfeld, Johannes |
author_facet | Lobenwein, Daniela Huber, Rosalie Kerbler, Lars Gratl, Alexandra Wipper, Sabine Gollmann-Tepeköylü, Can Holfeld, Johannes |
author_sort | Lobenwein, Daniela |
collection | PubMed |
description | Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same applies for pre- or postconditioning remains unclear. In a model of cultured SHSY-5Y cells, preconditioning with either poly(I:C), a TLR3 agonist, or SWT was performed before induction of hypoxia, whereas postconditioning treatment was performed after termination of hypoxia. We measured cytokine expression via RT-PCR and utilized Western blot analysis for the analysis of signaling and apoptosis. TLR3 activation via poly(I:C) significantly reduced apoptotic markers in both pre- and postconditioning, the former yielding more favorable results through an additional suppression of TLR4 and its downstream signaling. On the contrary, SWT showed slightly more favorable effects in the setting of postconditioning with significantly reduced markers of apoptosis. Pre- and post-ischemic direct TLR3 activation as well as post-ischemic SWT can decrease apoptosis and proinflammatory cytokine expression significantly in vitro and might therefore pose possible new treatment strategies for ischemic spinal cord injury. |
format | Online Article Text |
id | pubmed-9027844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90278442022-04-23 Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study Lobenwein, Daniela Huber, Rosalie Kerbler, Lars Gratl, Alexandra Wipper, Sabine Gollmann-Tepeköylü, Can Holfeld, Johannes J Clin Med Article Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same applies for pre- or postconditioning remains unclear. In a model of cultured SHSY-5Y cells, preconditioning with either poly(I:C), a TLR3 agonist, or SWT was performed before induction of hypoxia, whereas postconditioning treatment was performed after termination of hypoxia. We measured cytokine expression via RT-PCR and utilized Western blot analysis for the analysis of signaling and apoptosis. TLR3 activation via poly(I:C) significantly reduced apoptotic markers in both pre- and postconditioning, the former yielding more favorable results through an additional suppression of TLR4 and its downstream signaling. On the contrary, SWT showed slightly more favorable effects in the setting of postconditioning with significantly reduced markers of apoptosis. Pre- and post-ischemic direct TLR3 activation as well as post-ischemic SWT can decrease apoptosis and proinflammatory cytokine expression significantly in vitro and might therefore pose possible new treatment strategies for ischemic spinal cord injury. MDPI 2022-04-11 /pmc/articles/PMC9027844/ /pubmed/35456206 http://dx.doi.org/10.3390/jcm11082115 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lobenwein, Daniela Huber, Rosalie Kerbler, Lars Gratl, Alexandra Wipper, Sabine Gollmann-Tepeköylü, Can Holfeld, Johannes Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study |
title | Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study |
title_full | Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study |
title_fullStr | Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study |
title_full_unstemmed | Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study |
title_short | Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study |
title_sort | neuronal pre- and postconditioning via toll-like receptor 3 agonist or extracorporeal shock wave therapy as new treatment strategies for spinal cord ischemia: an in vitro study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027844/ https://www.ncbi.nlm.nih.gov/pubmed/35456206 http://dx.doi.org/10.3390/jcm11082115 |
work_keys_str_mv | AT lobenweindaniela neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy AT huberrosalie neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy AT kerblerlars neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy AT gratlalexandra neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy AT wippersabine neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy AT gollmanntepekoylucan neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy AT holfeldjohannes neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy |